Whit Mayo
Stock Analyst at Leerink Partners
(2.50)
# 2,374
Out of 4,918 analysts
166
Total ratings
51.52%
Success rate
10.23%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $283.08 | +9.51% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $6.61 | -62.18% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $8.97 | +22.63% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $6.72 | +19.05% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $10.60 | +135.85% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $249.87 | +0.05% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $110.11 | -9.18% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $20.65 | -27.36% | 1 | Feb 20, 2024 | |
| UNH UnitedHealth Group | Maintains: Outperform | $625 → $560 | $249.56 | +124.39% | 11 | Jun 14, 2023 | |
| UHS Universal Health Services | Upgrades: Outperform | n/a | $166.45 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $111.75 | -13.20% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $267.38 | +25.29% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $98.60 | -13.79% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $353.99 | -19.21% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $21.97 | +82.07% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $19.54 | +99.59% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.89 | -48.10% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $1.79 | +1,575.98% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $12.25 | +30.61% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $161.28 | -65.90% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $21.77 | +373.13% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $97.80 | +78.94% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $13.78 | +37.88% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.60 | +53.85% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $260.08 | -21.95% | 2 | May 1, 2018 |
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $283.08
Upside: +9.51%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $6.61
Upside: -62.18%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $8.97
Upside: +22.63%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $6.72
Upside: +19.05%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $10.60
Upside: +135.85%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $249.87
Upside: +0.05%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $110.11
Upside: -9.18%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $20.65
Upside: -27.36%
UnitedHealth Group
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $249.56
Upside: +124.39%
Universal Health Services
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $166.45
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $111.75
Upside: -13.20%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $267.38
Upside: +25.29%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $98.60
Upside: -13.79%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $353.99
Upside: -19.21%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $21.97
Upside: +82.07%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $19.54
Upside: +99.59%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.89
Upside: -48.10%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $1.79
Upside: +1,575.98%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $12.25
Upside: +30.61%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $161.28
Upside: -65.90%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $21.77
Upside: +373.13%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $97.80
Upside: +78.94%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $13.78
Upside: +37.88%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.60
Upside: +53.85%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $260.08
Upside: -21.95%